SCHEMBL5849326

SCHEMBL5849326

CCCCCc1cc2c(N3CCN(C(=O)OC(C)(C)C)CC3)ncnc2s1

nearest known ligand 0.55

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
P2RY12 Q9H244 6/20 0.55
MEN1 O00255 9/20 0.53
KMT2A Q03164 5/20 0.53
ALDH1A1 P00352 2/20 0.50
HRH4 Q9H3N8 1/20 0.49
KIT P10721 1/20 0.48
HTT P42858 2/20 0.48
TSHR P16473 3/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
MAPT P10636 2/20 0.47
RXFP1 Q9HBX9 1/20 0.47
KDM4E B2RXH2 1/20 0.47
LMNA P02545 1/20 0.47
TP53 P04637 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5849427 0.93 P2RY12 (0.57) P2RY12MEN1KMT2AALDH1A1HRH4
SCHEMBL5850552 0.89 P2RY12 (0.68) P2RY12MEN1KMT2AALDH1A1HRH4
SCHEMBL7062968 0.86 MEN1 (0.61) P2RY12MEN1KMT2AALDH1A1HRH4
SCHEMBL5849216 0.85 P2RY12 (0.55) P2RY12MEN1KMT2AALDH1A1HRH4
SCHEMBL5849479 0.84 P2RY12 (0.62) P2RY12MEN1KMT2AALDH1A1HRH4
SCHEMBL5850896 0.83 P2RY12 (0.80) P2RY12MEN1KMT2AALDH1A1HRH4
SCHEMBL5849270 0.82 P2RY12 (0.62) P2RY12MEN1KMT2AALDH1A1HRH4
SCHEMBL5849430 0.81 P2RY12 (0.58) P2RY12MEN1KMT2AALDH1A1HRH4
SCHEMBL5851682 0.81 KIT (0.55) P2RY12MEN1KMT2AALDH1A1HRH4
SCHEMBL5851715 0.81 MAPT (0.57) P2RY12MEN1KMT2AALDH1A1KIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7115741-B2 4-thieno[2,3-D]pyrimidin-4-YL piperazine compounds ALEXION PHARMACEUTICALS, INC. 2006-10-03 US disclosed
WO-2003022214-A2 PIPERAZINE AND HOMOPIPERAZINE COMPOUNDS MILLENNIUM PHARMACEUTICALS, INC. (US) 2003-03-20 WO disclosed